- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02520167
Partnership to Improve Nutrition and Adiposity in Prenatal Clinical Care: a Pilot and Feasibility Study
July 10, 2017 updated by: University of Colorado, Denver
This study will pilot and assess feasibility of a prenatal intervention for obese pregnant women based on the Diabetes Prevention Program (DPP).
Intervention group participants will meet with a clinic dietitian for 15 minutes at every prenatal appointment to complete a DPP-based curriculum and receive breastfeeding education.
Control group participants will receive usual prenatal care.
Outcomes include reach and dose of the intervention, gestational weight gain, dietary intake, physical activity, and breastfeeding in the first 6 weeks postpartum.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study will pilot and test feasibility of a prenatal lifestyle intervention designed to limit gestational weight gain and prevent gestational diabetes.
The intervention is based on the Diabetes Prevention Program lifestyle intervention, will include prenatal breastfeeding education and online peer group support, and will be integrated into the participants' regular prenatal appointments.
Women (n=24) will be enrolled in early pregnancy.
After baseline assessments (demographics, maternal diet, physical activity, mental health), women randomized equally to the intervention or usual care conditions.
Further data collection will occur at approximately 24 weeks gestation, 36 weeks gestation, and 6 weeks postpartum, and clinical data (weight, pregnancy and obstetric complications) will be abstracted from medical records at the end of the study.
Outcomes include reach and dose of the intervention, gestational weight gain, dietary intake, physical activity, and breastfeeding in the first 6 weeks postpartum.
The investigators hypothesize that the intervention will reduce gestational weight gain, improve maternal dietary intake, increase total energy expenditure, and increase breastfeeding exclusivity in the first 6 weeks postpartum.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Denver, Colorado, United States, 80205
- Denver Health Eastside Family Health Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Singleton pregnancies of <12 weeks gestation
- Pre-pregnant body mass index >=30
- Speak and understand English
- Plan to continue care at the clinic through pregnancy and postpartum
Exclusion Criteria:
- Pre-existing diabetes
- History of serious chronic illnesses
- History of prior gestational diabetes
- Prior delivery at <37 weeks gestation
- Prior delivery of infant weighing <2500g
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Dietary and Lifestyle Counseling
Women randomized to the intervention group will meet with a dietary counselor for 15 minutes at every prenatal appointment.
They will receive a dietary and lifestyle curriculum based on the Diabetes Prevention Program curriculum (11 lessons) with one additional lesson providing prenatal breastfeeding education.
They will also have access to a private online Facebook page for additional education and peer group support.
|
Dietary and lifestyle education; Peer group support.
|
|
No Intervention: Standard of Care
Usual prenatal care consists of regular clinical appointments, pregnancy ultrasounds, and recommendations to use prenatal multivitamins, eat a balanced diet, and remain physically active.
Women with a pre-pregnant body mass index > 30 complete early glucose screening (as early as possible after presentation at the clinic) to detect pre-existing diabetes, and all women undergo routine gestational diabetes screening at 24-28 weeks.
Women who test positive for pre-existing diabetes or gestational diabetes are referred to a registered dietitian.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gestational weight gain
Time Frame: 40 weeks
|
Weight change from pre-pregnancy to time of delivery
|
40 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maternal fruit intake
Time Frame: Assessed from 12 weeks gestation through 6 weeks postpartum
|
Change in daily servings of fruit from early pregnancy to mid-pregnancy, late pregnancy, and postpartum
|
Assessed from 12 weeks gestation through 6 weeks postpartum
|
|
Maternal vegetable intake
Time Frame: Assessed from 12 weeks gestation through 6 weeks postpartum
|
Change in daily servings of vegetables from early pregnancy to mid-pregnancy, late pregnancy, and postpartum
|
Assessed from 12 weeks gestation through 6 weeks postpartum
|
|
Maternal whole grains intake
Time Frame: Assessed from 12 weeks gestation through 6 weeks postpartum
|
Change in daily servings of whole grains from early pregnancy to mid-pregnancy, late pregnancy, and postpartum
|
Assessed from 12 weeks gestation through 6 weeks postpartum
|
|
Maternal solid fats intake
Time Frame: Assessed from 12 weeks gestation through 6 weeks postpartum
|
Change in daily servings of solid fats from early pregnancy to mid-pregnancy, late pregnancy, and postpartum
|
Assessed from 12 weeks gestation through 6 weeks postpartum
|
|
Maternal added sugars intake
Time Frame: Assessed from 12 weeks gestation through 6 weeks postpartum
|
Change in daily servings of added sugars from early pregnancy to mid-pregnancy, late pregnancy, and postpartum
|
Assessed from 12 weeks gestation through 6 weeks postpartum
|
|
Maternal physical activity
Time Frame: Assessed from 12 weeks gestation through 6 weeks postpartum
|
Change in total estimated energy expenditure from early pregnancy to mid-pregnancy, late pregnancy, and postpartum
|
Assessed from 12 weeks gestation through 6 weeks postpartum
|
|
Exclusive breastfeeding
Time Frame: Assessed at 6 weeks postpartum
|
Measured as exclusive breastfeeding (no formula, no complementary foods) in the first 6 weeks postpartum
|
Assessed at 6 weeks postpartum
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Katherine A Sauder, PhD, University of Colorado, Denver
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2015
Primary Completion (Actual)
July 1, 2017
Study Completion (Actual)
July 1, 2017
Study Registration Dates
First Submitted
August 5, 2015
First Submitted That Met QC Criteria
August 6, 2015
First Posted (Estimate)
August 11, 2015
Study Record Updates
Last Update Posted (Actual)
July 13, 2017
Last Update Submitted That Met QC Criteria
July 10, 2017
Last Verified
July 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15-0760
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Individual participant data will not be made available for this small pilot and feasibility study
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Kafrelsheikh UniversityNot yet recruitingEctopic PregnancyEgypt
-
Meir Medical CenterRecruiting
-
Bagcilar Training and Research HospitalRecruitingEctopic PregnancyTurkey (Türkiye)
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
MELISA Institute Genomics & Proteomics Research...RecruitingHealthy | Pregnancy | Early Pregnancy | Early Pregnancy Loss | ChildbirthChile
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
-
Zagazig UniversityCompleted
Clinical Trials on Dietary and Lifestyle Counseling
-
Carolinas Medical CenterTerminatedObesity | PregnancyUnited States
-
Instituto Aragones de Ciencias de la SaludCompletedHypertriglyceridemia | HyperferritinemiaSpain
-
AstraZenecaTerminatedType 2 DiabetesCzech Republic, France, Poland, Philippines, Estonia, Latvia, Lithuania, Norway, Hungary, Slovakia, Greece, Sweden, Australia, Former Serbia and Montenegro
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedObstructive Sleep Apnea | Sleep Apnea | Sleep-disordered BreathingUnited States
-
Kuopio University HospitalUniversity of Eastern Finland; Finnish Institute for Health and WelfareUnknownObstructive Sleep ApneaFinland
-
York UniversityPublic Health Agency of Canada (PHAC)Unknown
-
Catalysis SLCompletedInsulin Resistance | Nonalcoholic SteatohepatitisCuba
-
Chinese Academy of SciencesCompleted
-
Institute of Cardiology, Warsaw, PolandUnknownCoronary Artery DiseasePoland